West Pharmaceutical (WST) SVP awarded restricted stock units and options

robot
Abstract generation in progress

West Pharmaceutical Services (WST) Senior Vice President of Strategy & Corporate Development, Rodolphe Jean Poussot, was granted 437 restricted stock units and stock options for 1,040 shares on March 1, 2026. These equity awards, which vest in four equal annual installments starting March 1, 2027, represent additional compensation tied to the company’s common stock. The transactions were reported in a Form 4 SEC filing, indicating an increase in his potential future ownership in the company.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin